CD8A and neoplasm: Tumor epitopes that are recognized by CD8+ T cells can be classified in tumor-specific antigens (TSA), which are only expressed in tumors due to mutations or fusions resulting from chromosomal translocation and tumor-associated antigens (TAA), also expressed by healthy cells but in altered amounts or locations such as cancer testis antigens, differentiation antigens, or viral antigens.